Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Sorafenib Tosylate Tablets Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Sorafenib Tosylate Tablets Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 94 Pages

Report ld: 1347628

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma.

Sorafenib Tosylate Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sorafenib Tosylate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Online Sale are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Sorafenib Tosylate Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Sorafenib Tosylate Tablets key manufacturers include Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd., Chongqing Yaoyou Pharmaceutical Co., Ltd., Jiangxi Shanxiang Pharmaceutical Co., Ltd. and CSPC Ouyi Pharmaceutical Co., Ltd., etc. Bayer, Cipla, Beijing Yabao Biological Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.

Sorafenib Tosylate Tablets can be divided into 60 Pieces/Box, 120 Pieces/Box and Others,, etc. 60 Pieces/Box is the mainstream product in the market, accounting for % sales share globally in 2022.

Sorafenib Tosylate Tablets is widely used in various fields, such as Hospital, Online Sale, Pharmacy and Others, etc. Hospital provides greatest supports to the Sorafenib Tosylate Tablets industry development. In 2022, global % sales of Sorafenib Tosylate Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sorafenib Tosylate Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Bayer
Cipla
Beijing Yabao Biological Pharmaceutical Co., Ltd.
Chongqing Yaoyou Pharmaceutical Co., Ltd.
Jiangxi Shanxiang Pharmaceutical Co., Ltd.
CSPC Ouyi Pharmaceutical Co., Ltd.

Segment by Type
60 Pieces/Box
120 Pieces/Box
Others

Segment by Application
Hospital
Online Sale
Pharmacy
Others

Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Sorafenib Tosylate Tablets market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sorafenib Tosylate Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sorafenib Tosylate Tablets industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Sorafenib Tosylate Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sorafenib Tosylate Tablets introduction, etc. Sorafenib Tosylate Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Sorafenib Tosylate Tablets market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.

 1 Sorafenib Tosylate Tablets Market Overview
    1.1 Sorafenib Tosylate Tablets Product Overview
    1.2 Sorafenib Tosylate Tablets Market Segment by Type
        1.2.1 60 Pieces/Box
        1.2.2 120 Pieces/Box
        1.2.3 Others
    1.3 Global Sorafenib Tosylate Tablets Market Size by Type
        1.3.1 Global Sorafenib Tosylate Tablets Market Size Overview by Type (2018-2029)
        1.3.2 Global Sorafenib Tosylate Tablets Historic Market Size Review by Type (2018-2023)
        1.3.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Type (2024-2029)
    1.4 Key Regions Market Size Segment by Type
        1.4.1 North America Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
        1.4.2 Europe Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
        1.4.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
        1.4.4 Latin America Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)
        1.4.5 Middle East and Africa Sorafenib Tosylate Tablets Sales Breakdown by Type (2018-2023)

 2 Global Sorafenib Tosylate Tablets Market Competition by Company
    2.1 Global Top Players by Sorafenib Tosylate Tablets Sales (2018-2023)
    2.2 Global Top Players by Sorafenib Tosylate Tablets Revenue (2018-2023)
    2.3 Global Top Players by Sorafenib Tosylate Tablets Price (2018-2023)
    2.4 Global Top Manufacturers Sorafenib Tosylate Tablets Manufacturing Base Distribution, Sales Area, Product Type
    2.5 Sorafenib Tosylate Tablets Market Competitive Situation and Trends
        2.5.1 Sorafenib Tosylate Tablets Market Concentration Rate (2018-2023)
        2.5.2 Global 5 and 10 Largest Manufacturers by Sorafenib Tosylate Tablets Sales and Revenue in 2022
    2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sorafenib Tosylate Tablets as of 2022)
    2.7 Date of Key Manufacturers Enter into Sorafenib Tosylate Tablets Market
    2.8 Key Manufacturers Sorafenib Tosylate Tablets Product Offered
    2.9 Mergers & Acquisitions, Expansion

 3 Sorafenib Tosylate Tablets Status and Outlook by Region
    3.1 Global Sorafenib Tosylate Tablets Market Size and CAGR by Region: 2018 VS 2022 VS 2029
    3.2 Global Sorafenib Tosylate Tablets Historic Market Size by Region
        3.2.1 Global Sorafenib Tosylate Tablets Sales in Volume by Region (2018-2023)
        3.2.2 Global Sorafenib Tosylate Tablets Sales in Value by Region (2018-2023)
        3.2.3 Global Sorafenib Tosylate Tablets Sales (Volume & Value) Price and Gross Margin (2018-2023)
    3.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Region
        3.3.1 Global Sorafenib Tosylate Tablets Sales in Volume by Region (2024-2029)
        3.3.2 Global Sorafenib Tosylate Tablets Sales in Value by Region (2024-2029)
        3.3.3 Global Sorafenib Tosylate Tablets Sales (Volume & Value), Price and Gross Margin (2024-2029)

 4 Global Sorafenib Tosylate Tablets by Application
    4.1 Sorafenib Tosylate Tablets Market Segment by Application
        4.1.1 Hospital
        4.1.2 Online Sale
        4.1.3 Pharmacy
        4.1.4 Others
    4.2 Global Sorafenib Tosylate Tablets Market Size by Application
        4.2.1 Global Sorafenib Tosylate Tablets Market Size Overview by Application (2018-2029)
        4.2.2 Global Sorafenib Tosylate Tablets Historic Market Size Review by Application (2018-2023)
        4.2.3 Global Sorafenib Tosylate Tablets Forecasted Market Size by Application (2024-2029)
    4.3 Key Regions Market Size Segment by Application
        4.3.1 North America Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
        4.3.2 Europe Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
        4.3.3 Asia-Pacific Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
        4.3.4 Latin America Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)
        4.3.5 Middle East and Africa Sorafenib Tosylate Tablets Sales Breakdown by Application (2018-2023)

 5 North America Sorafenib Tosylate Tablets by Country
    5.1 North America Sorafenib Tosylate Tablets Historic Market Size by Country
        5.1.1 North America Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        5.1.2 North America Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
        5.1.3 North America Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
    5.2 North America Sorafenib Tosylate Tablets Forecasted Market Size by Country
        5.2.1 North America Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
        5.2.2 North America Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)

 6 Europe Sorafenib Tosylate Tablets by Country
    6.1 Europe Sorafenib Tosylate Tablets Historic Market Size by Country
        6.1.1 Europe Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        6.1.2 Europe Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
        6.1.3 Europe Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
    6.2 Europe Sorafenib Tosylate Tablets Forecasted Market Size by Country
        6.2.1 Europe Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
        6.2.2 Europe Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)

 7 Asia-Pacific Sorafenib Tosylate Tablets by Region
    7.1 Asia-Pacific Sorafenib Tosylate Tablets Historic Market Size by Region
        7.1.1 Asia-Pacific Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
        7.1.2 Asia-Pacific Sorafenib Tosylate Tablets Sales in Volume by Region (2018-2023)
        7.1.3 Asia-Pacific Sorafenib Tosylate Tablets Sales in Value by Region (2018-2023)
    7.2 Asia-Pacific Sorafenib Tosylate Tablets Forecasted Market Size by Region
        7.2.1 Asia-Pacific Sorafenib Tosylate Tablets Sales in Volume by Region (2024-2029)
        7.2.2 Asia-Pacific Sorafenib Tosylate Tablets Sales in Value by Region (2024-2029)

 8 Latin America Sorafenib Tosylate Tablets by Country
    8.1 Latin America Sorafenib Tosylate Tablets Historic Market Size by Country
        8.1.1 Latin America Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        8.1.2 Latin America Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
        8.1.3 Latin America Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
    8.2 Latin America Sorafenib Tosylate Tablets Forecasted Market Size by Country
        8.2.1 Latin America Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
        8.2.2 Latin America Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)

 9 Middle East and Africa Sorafenib Tosylate Tablets by Country
    9.1 Middle East and Africa Sorafenib Tosylate Tablets Historic Market Size by Country
        9.1.1 Middle East and Africa Sorafenib Tosylate Tablets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
        9.1.2 Middle East and Africa Sorafenib Tosylate Tablets Sales in Volume by Country (2018-2023)
        9.1.3 Middle East and Africa Sorafenib Tosylate Tablets Sales in Value by Country (2018-2023)
    9.2 Middle East and Africa Sorafenib Tosylate Tablets Forecasted Market Size by Country
        9.2.1 Middle East and Africa Sorafenib Tosylate Tablets Sales in Volume by Country (2024-2029)
        9.2.2 Middle East and Africa Sorafenib Tosylate Tablets Sales in Value by Country (2024-2029)

 10 Company Profiles
    10.1 Bayer
        10.1.1 Bayer Company Information
        10.1.2 Bayer Introduction and Business Overview
        10.1.3 Bayer Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
        10.1.4 Bayer Sorafenib Tosylate Tablets Products Offered
        10.1.5 Bayer Recent Development
    10.2 Cipla
        10.2.1 Cipla Company Information
        10.2.2 Cipla Introduction and Business Overview
        10.2.3 Cipla Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
        10.2.4 Cipla Sorafenib Tosylate Tablets Products Offered
        10.2.5 Cipla Recent Development
    10.3 Beijing Yabao Biological Pharmaceutical Co., Ltd.
        10.3.1 Beijing Yabao Biological Pharmaceutical Co., Ltd. Company Information
        10.3.2 Beijing Yabao Biological Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.3.3 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
        10.3.4 Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
        10.3.5 Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Development
    10.4 Chongqing Yaoyou Pharmaceutical Co., Ltd.
        10.4.1 Chongqing Yaoyou Pharmaceutical Co., Ltd. Company Information
        10.4.2 Chongqing Yaoyou Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.4.3 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
        10.4.4 Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
        10.4.5 Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Development
    10.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd.
        10.5.1 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Company Information
        10.5.2 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.5.3 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
        10.5.4 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
        10.5.5 Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Development
    10.6 CSPC Ouyi Pharmaceutical Co., Ltd.
        10.6.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
        10.6.2 CSPC Ouyi Pharmaceutical Co., Ltd. Introduction and Business Overview
        10.6.3 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales, Revenue and Gross Margin (2018-2023)
        10.6.4 CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Products Offered
        10.6.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development

 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
    11.1 Sorafenib Tosylate Tablets Key Raw Materials
        11.1.1 Key Raw Materials
        11.1.2 Key Raw Materials Price
        11.1.3 Raw Materials Key Suppliers
    11.2 Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Sorafenib Tosylate Tablets Industrial Chain Analysis
    11.4 Sorafenib Tosylate Tablets Market Dynamics
        11.4.1 Sorafenib Tosylate Tablets Industry Trends
        11.4.2 Sorafenib Tosylate Tablets Market Drivers
        11.4.3 Sorafenib Tosylate Tablets Market Challenges
        11.4.4 Sorafenib Tosylate Tablets Market Restraints

 12 Market Strategy Analysis, Distributors
    12.1 Sales Channel
    12.2 Sorafenib Tosylate Tablets Distributors
    12.3 Sorafenib Tosylate Tablets Downstream Customers

 13 Research Findings and Conclusion

 14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer

List of Tables
    Table 1. Major Company of 60 Pieces/Box
    Table 2. Major Company of 120 Pieces/Box
    Table 3. Major Company of Others
    Table 4. Global Sorafenib Tosylate Tablets Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (K Units)
    Table 6. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Sorafenib Tosylate Tablets Market Share in Value by Type (2018-2023)
    Table 9. Global Sorafenib Tosylate Tablets Price by Type (2018-2023) & (US$/Unit)
    Table 10. Global Sorafenib Tosylate Tablets Sales by Type (2024-2029) & (K Units)
    Table 11. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Sorafenib Tosylate Tablets Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Sorafenib Tosylate Tablets Price by Type (2024-2029) & (US$/Unit)
    Table 15. North America Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (K Units)
    Table 16. North America Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023)
    Table 18. Europe Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023)
    Table 22. Latin America Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Sorafenib Tosylate Tablets Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa Sorafenib Tosylate Tablets Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Sorafenib Tosylate Tablets Sales by Company (2018-2023) & (K Units)
    Table 26. Global Sorafenib Tosylate Tablets Sales Share by Company (2018-2023)
    Table 27. Global Sorafenib Tosylate Tablets Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Sorafenib Tosylate Tablets Revenue Share by Company (2018-2023)
    Table 29. Global Market Sorafenib Tosylate Tablets Price by Company (2018-2023) & (US$/Unit)
    Table 30. Global Sorafenib Tosylate Tablets Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Sorafenib Tosylate Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sorafenib Tosylate Tablets as of 2022)
    Table 33. Date of Key Manufacturers Enter into Sorafenib Tosylate Tablets Market
    Table 34. Key Manufacturers Sorafenib Tosylate Tablets Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Sorafenib Tosylate Tablets Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (K Units)
    Table 38. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 42. Global Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (K Units)
    Table 43. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Sorafenib Tosylate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
    Table 47. Global Sorafenib Tosylate Tablets Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (K Units)
    Table 49. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Sorafenib Tosylate Tablets Price by Application (2018-2023) & (US$/Unit)
    Table 53. Global Sorafenib Tosylate Tablets Sales by Application (2024-2029) & (K Units)
    Table 54. Global Sorafenib Tosylate Tablets Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Sorafenib Tosylate Tablets Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Sorafenib Tosylate Tablets Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Sorafenib Tosylate Tablets Price by Application (2024-2029) & (US$/Unit)
    Table 58. North America Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) 
    Table 59. North America Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) 
    Table 61. Europe Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) 
    Table 63. Asia-Pacific Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) 
    Table 65. Latin America Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2018-2023) (K Units) 
    Table 67. Middle East and Africa Sorafenib Tosylate Tablets Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units)
    Table 69. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units)
    Table 73. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units)
    Table 77. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units)
    Table 81. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Sorafenib Tosylate Tablets Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Sorafenib Tosylate Tablets Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Country (2024-2029)
    Table 108. Bayer Company Information
    Table 109. Bayer Introduction and Business Overview
    Table 110. Bayer Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 111. Bayer Sorafenib Tosylate Tablets Product
    Table 112. Bayer Recent Development
    Table 113. Cipla Company Information
    Table 114. Cipla Introduction and Business Overview
    Table 115. Cipla Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 116. Cipla Sorafenib Tosylate Tablets Product
    Table 117. Cipla Recent Development
    Table 118. Beijing Yabao Biological Pharmaceutical Co., Ltd. Company Information
    Table 119. Beijing Yabao Biological Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 120. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 121. Beijing Yabao Biological Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
    Table 122. Beijing Yabao Biological Pharmaceutical Co., Ltd. Recent Development
    Table 123. Chongqing Yaoyou Pharmaceutical Co., Ltd. Company Information
    Table 124. Chongqing Yaoyou Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 125. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 126. Chongqing Yaoyou Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
    Table 127. Chongqing Yaoyou Pharmaceutical Co., Ltd. Recent Development
    Table 128. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Company Information
    Table 129. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 130. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 131. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
    Table 132. Jiangxi Shanxiang Pharmaceutical Co., Ltd. Recent Development
    Table 133. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
    Table 134. CSPC Ouyi Pharmaceutical Co., Ltd. Introduction and Business Overview
    Table 135. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
    Table 136. CSPC Ouyi Pharmaceutical Co., Ltd. Sorafenib Tosylate Tablets Product
    Table 137. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development
    Table 138. Key Raw Materials Lists
    Table 139. Raw Materials Key Suppliers Lists
    Table 140. Sorafenib Tosylate Tablets Market Trends
    Table 141. Sorafenib Tosylate Tablets Market Drivers
    Table 142. Sorafenib Tosylate Tablets Market Challenges
    Table 143. Sorafenib Tosylate Tablets Market Restraints
    Table 144. Sorafenib Tosylate Tablets Distributors List
    Table 145. Sorafenib Tosylate Tablets Downstream Customers
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sorafenib Tosylate Tablets Product Picture
    Figure 2. Global Sorafenib Tosylate Tablets Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Sorafenib Tosylate Tablets Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Sorafenib Tosylate Tablets Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of 60 Pieces/Box
    Figure 6. Global 60 Pieces/Box Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of 120 Pieces/Box
    Figure 8. Global 120 Pieces/Box Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of Others
    Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global Sorafenib Tosylate Tablets Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Sorafenib Tosylate Tablets Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022
    Figure 14. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022
    Figure 15. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Sorafenib Tosylate Tablets Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Sorafenib Tosylate Tablets Revenue in 2022
    Figure 25. Sorafenib Tosylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of Hospital
    Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Online Sale
    Figure 29. Global Online Sale Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Product Picture of Pharmacy
    Figure 31. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)
    Figure 32. Product Picture of Others
    Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 34. Global Sorafenib Tosylate Tablets Sales by Application (2018-2029) & (US$ Million)
    Figure 35. Global Sorafenib Tosylate Tablets Sales Market Share by Application in 2022 & 2029
    Figure 36. North America Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022
    Figure 37. North America Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022
    Figure 38. Europe Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022
    Figure 39. Europe Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022
    Figure 40. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022
    Figure 41. Asia-Pacific Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022
    Figure 42. Latin America Sorafenib Tosylate Tablets Sales Market Share in Volume by Application in 2022
    Figure 43. Latin America Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022
    Figure 44. Middle East and Africa Sorafenib Tosylate Tablets Sales Market Share in Value by Application in 2022
    Figure 45. Key Raw Materials Price
    Figure 46. Sorafenib Tosylate Tablets Manufacturing Cost Structure
    Figure 47. Sorafenib Tosylate Tablets Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed

Sorafenib tosylate Tablets are used as clinical anticancer agents for the treatment of liver and renal cell carcinoma.

Sorafenib Tosylate Tablets report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sorafenib Tosylate Tablets market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Online Sale are the major drivers for the industry.

Sorafenib Tosylate Tablets can be divided into 60 Pieces/Box, 120 Pieces/Box and Others,, etc. 60 Pieces/Box is the mainstream product in the market, accounting for % sales share globally in 2022.

Segment by Type
60 Pieces/Box
120 Pieces/Box
Others

Segment by Application
Hospital
Online Sale
Pharmacy
Others

Industry: Pharma & Healthcare

Published: 2023-06-05

Pages: 94 Pages

Report ld: 1347628

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License